Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
October 16, 2023 Cover
Volume 101, Issue 34
Thanks to advances in materials science, temporary implants that remove themselves by dissolving in the body could soon make their clinical debut
Degradable electronic medical devices power up
Thanks to advances in materials science, temporary implants that remove themselves by dissolving in the body could soon make their clinical debut
Private equity ramps up in pharmaceutical services
A yearslong incursion has accelerated, transforming a small-company chemical sector
Can chemists turn wood into an electronic material?
Tapping into the renewable material’s unique nanostructure, scientists pursue surprising devices and potential killer apps
-
Carbon dioxide industry stresses about supply
Sequestration may pull carbon dioxide from an already tight merchant market
-
Being accessible and discussing disabilities and health issues
Ensure communications are broadly accessible. And brush up on ways to skillfully navigate conversations around disabilities, disorders, and other matters of health
-
Molecule packs dual punch for cancer immunotherapy
First of its kind inhibitor accesses hard-to-drug phosphatase active sites to target tumors for destruction
ADVERTISEMENT
Atoms swap spots in aromatic rings
New reaction replaces carbon with nitrogen
